Position in JUNS
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$253,908
-$125,953 QoQ
Shares Held
248,931
+15.3% QoQ
Ownership
0.686%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 35%
None 65%
Common Shares in JUNS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $67,131,631,269 across 450 Biotechnology names. JUNS ranks #399 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | QNCX |
Quince Therapeutics, Inc.
|
2,084,015 | $1,396,290,050 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 |
All Filings in JUNS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $253,908 | 248,931 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $379,861 | 215,831 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||